Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study of a combination therapy of hydroxychloroquine and atorvastatin is
to learn about the effects in inflammation and pain in patients with Osteoarthritis of the
knee. These medications are FDA approved and commercially available.